mRNA-1345 demonstrated vaccine efficacy of 83.7% against RSV lower respiratory tract disease, defined by 2 or more symptoms in older adults
The goal of Dozee’s partnership with BII is to improve access to healthcare across India and alleviate the workload of healthcare workers, reduce nurse burnout and fatigue in hospital wards
OriCiro's synthetic biology and enzyme technologies will support Moderna's expanding portfolio of therapeutics and vaccines
Collaboration to generate and develop therapeutics for oncology and non-oncology conditions
Moderna and Merck announced mRNA-4157/V940, in combination with KEYTRUDA, demonstrated a 44% reduction in the risk of disease recurrence or death in melanoma patients
Passengers arriving from 6 high-risk countries are now mandatorily required to upload their negative RT-PCR test
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
Results are the first demonstration of efficacy for an investigational mRNA cancer treatment in a randomized clinical trial
Timely screening and accurate detection through precision diagnostics, targeted therapy, risk reducing surgeries, and comprehensive multimodality treatment options have resulted in improving survival rates and quality of life in cancer patients in India
API platform to comprise of RA Chem Pharma, ZCL Chemicals and Avra Laboratories
Subscribe To Our Newsletter & Stay Updated
